期刊文献+

新型三唑类衍生物的合成及其抗真菌活性研究

Synthesis and antifungal activities of novel triazole derivatives
下载PDF
导出
摘要 目的 研究具有萘苄结构的三唑醇类化合物的抗真菌活性。方法设计合成了9个目标化合物;其结构通过H NMR、MS确证,选择8种真菌为实验菌株,根据美国国家临床实验室标准委员会(NCCLS)推荐的标准化抗真菌敏感性实验方法,进行体外抑菌活性测试。结果所有化合物对所选真菌均表现出了一定的抑菌活性,化合物1c对除烟曲霉菌以外的其他7种真菌的MIC_(80)值<0.125μg/ml,是伏立康唑活性的16倍。结论引入萘环和烃基侧链的目标化合物都有抗真菌活性。 Objective To synthesize a new series of triazole compounds with naphthalene benzyl as side chain and evaluate the antifungal activity .Methods Nine title compounds were synthesized and determined by the 1 H NMR and MS spectra .According to the method recommended by the national committee for clinical laboratory standards (NCCLS), the RPMI-1640 test medium was used, the antifungal activities of all the compounds were evaluated against eight human pathogenic fungi in vitro.Results The title com-pounds exhibited potent antifungal activities .Compound 1c showed high activities against 7 funguses except Aspergillus fumigatus with the MIC80 values less than 0.125μg/ml, which was 16 times higher than that of Voriconazole .Conclusion The title compounds with naphthalene and alkyl substituent showed potent antifungal activities .
出处 《药学实践杂志》 CAS 2014年第3期186-190,共5页 Journal of Pharmaceutical Practice
基金 国家自然科学基金(20192188)
关键词 三唑类衍生物 化学合成 抗真菌活性 triazole derivatives chemical synthesis antifungal activity
  • 相关文献

参考文献1

二级参考文献15

  • 1B.J. Kullberg, A.M. Oude Lashof, Epidemiology of opportunistic invasive mycoses, Eur. J. Med. Res. 7 (2002) 183-191.
  • 2D.A. Enoch, H.A. Ludlam, N.M. Brown, lnvasive fungal infections: a review of epidemiology and management options, J. Med. Microbiol. 55 (2006) 809-818.
  • 3E. Rodriguez-Fernandez, J.L. Manzano, J.J. Benito, et al., Thiourea, triazole and thiadiazine compounds and their metal complexes as antifungal agents, J. Inorg. Biochem. 99 (2005) 1558-1572.
  • 4H. Hof, Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medi- cine? Drug Resist. Updat. 11 (2008) 25-31.
  • 5P. Eggimann, J. Garbino, D. Pittet, Management of Candida species infections in critically ill patients, Lancet Infect. Dis, 3 (2003) 772-785.
  • 6J. Peman, E. Canton, A. Espinel-lngroff, Antifungal drug resistance mechanisms, Expert. Rev, Anti, Infect. Ther. 7 (2009) 453-460.
  • 7A.K. Gupta, E. Tomas, New antifungal agents, Dermatol. Clin. 21 (2003) 565-576.
  • 8G.R. Thompson III, J. Cadena, T.F. Patterson, Overview of antifungal agents, Clin. Chest Med. 30 (2009) 203-215.
  • 9H. Ji, W. Zhang, Y. Zhou, et al., A three-dimensional model of lanosterol 14alpha- demethylase of Candida albicans and its interaction with azole antifungals, J. Med. Chem. 43 (2000) 2493-2505.
  • 10Z. Guan, X. Chai, S. Yu, et al., Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents, Chem. Biol. Drug. Des. 76 (2010) 496-504.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部